martes, 26 de noviembre de 2024

FDA approves drug for heart disorder caused by transthyretin-mediated amyloidosis

https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-drug-heart-disorder-caused-transthyretin-mediated-amyloidosis?utm_medium=email&utm_source=govdelivery

No hay comentarios:

Publicar un comentario